Transforming growth factor-β1 inhibits the production of IL-8 and the transmigration of neutrophils through activated endothelium

Journal of Immunology

Volumn 157, Issue 1, 1996, Pages 360-368

  Smith, William B ^a,b   Noack, Leanne ^a   Khew Goodall, Yeesim ^a   Isenmann, Sandra ^a   Vadas, Mathew A ^a   Gamble, Jennifer R ^a  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 8; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; DOSE TIME EFFECT RELATION; DRUG INHIBITION; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE ADHERENCE INHIBITION; LEUKOCYTE MIGRATION INHIBITION; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMANS; INTERLEUKIN-8; NEUTROPHIL ACTIVATION; NEUTROPHILS; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL VEINS;

EID: 0029994311     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Lawrence, M. B., and T. A. Springer. 1991. Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell 65:859.
2. Stricter, R. M., S. L. Kunkel, H. J. Showell, D. G. Remick, S. H. Phan, P. A. Ward, and R. M. Marks. 1989. Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-α, LPS and IL-1β. Science 243:1467.
3. Huber, A. R., S. L. Kunkel, R. F. Todd, and S. J. Weiss. 1991. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science 254:99.
4. Smith, W. B., J. R. Gamble, I. Clark-Lewis, and M. A. Vadas. 1991. Interleukin-8 induces neutrophil transendothelial migration. Immunology 72:65.
5. Smith, W. B., J. R. Gamble, I. Clark-Lewis, and M. A. Vadas. 1993. Chemotactic desensitization of neutrophils demonstrates interleukin-8 (IL-8)-dependent and IL-8-independent mechanisms of transmigration through cytokine-activated endothelium. Immunology 78:491.
6. Gamble, J. R., and M. A. Vadas. 1988. Endothelial adhesiveness for blood neutrophils is inhibited by transforming growth factor β. Science 242:97.
7. Gamble, J. R., and M. A. Vadas. 1991. Endothelial cell adhesiveness for human T lymphocytes is inhibited by transforming growth factor-β. J. Immunol. 146: 1149.
8. Gamble, J. R., Y. Khew-Goodall, and M. A. Vadas. 1993. Transforming growth factor-β inhibits E-selectin expression on human endothelial cells. J. Immunol. 150:4494.
9. Bereta, J., M. Bereta, F. D. Coffman, S. Cohen, and M. Cohen. 1992. Inhibition of basal and tumor necrosis factor-enhanced binding of murine tumor cells to murine endothelium by transforming growth factor-β. J. Immunol. 148:2932.
10. 1 and IL-4 regulate the adhesiveness of Peyer's patch high endothelial venule cells for lymphocytes. J. Immunol. 148:1106.
11. Gamble, J. R., J. M. Harlan, S. J. Klebanoff, and M. A. Vadas. 1985. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc. Natl. Acad. Sci. USA 82:8667.
12. Wall, R. T., L. A. Harker, L. J. Quadracci, and G. E. Striker. 1978. Factors influencing endothelial cell proliferation in vitro. J Cell. Physiol. 96:203.
13. Van Zee, K. J., L. E. DeForge, E. Fischer, M. A. Marano, J. S. Kenney, D. G. Remick, S. F. Lowry, and L. L. Moldawer. 1991. IL-8 in septic shock, endotoxemia and after IL-1 administration. J. Immunol. Methods 146:3478.
14. Chomczynski, P., and N. Sacchi. 1987. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 152: 156.
15. Goodall, G. J., and W. Filipowicz. 1989. The AU-rich sequences present in the intron of plant nuclear pre-mRNAs are required for splicing. Cell 58:4730.
16. Frater-Schroder, M., G. Muller, W. Birchmeier, and D. Bohla. 1986. Transforming growth factor-beta inhibits endothelial cell proliferation. Biochem. Biophys. Res. Commun. 137:295.
17. Heimark, R. L., D. R. Twardzik, and S. M. Schwartz. 1986. Inhibition of endothelial cell regeneration by type-beta transforming growth factor from platelets. Science 233:1078.
18. 1. Growth Factors 3:237.
19. Furie, M. B., M. J. Burns, M. C. A. Tancinco, C. D. Benjamin, and R. R. Lobb. 1992. E-selectin (endothelial leukocyte adhesion molecule-1) is not required for the migration of neutrophils across IL-1 stimulated endothelium in vitro. J. Immunol. 148:2395.
20. Drake, W. T., and A. C. Issekutz. 1993. Transforming growth factor-β1 enhances polymorphonuclear leukocyte accumulation in dermal inflammation and transendothelial migration by a priming action. Immunology 78:197.
21. Wahl, S. M., D. A. Hunt, L. M. Wakefield, N. McCartney-Francis, L. M. Wahl, A. B. Roberts, and M. B. Sporn. 1987. Transforming growth factor type β induces monocyte chemotaxis and growth factor production. Proc. Natl. Acad. Sci. USA 84:5788.
22. Brandes, M. E., U. E. H. Mai, K. Ohura, and S. M. Wahl. 1991. Type 1 transforming growth factor β receptors on neutrophils mediate chemotaxis to transforming growth factor-β. J. Immunol. 147:1600.
23. Border, W. A., and E. Ruoslahti. 1992. Transforming growth factor-β in disease: the dark side of tissue repair. J. Clin. Invest. 90:1.
24. McCartney-Francis, N. L., and S. M. Wahl. 1994. Transforming growth factor β: a matter of life and death. J. Leukocyte Biol. 55:401.
25. Majesky, M. W., L. Volkhard, D. R. Twardzik, S. M. Schwartz, and M. A. Reidy. 1991. Production of transforming growth factor β1 during repair of arterial injury. J. Clin. Invest. 88:904.
26. Antonelli-Orlidge, A., K. B. Saunders, S. R. Smith, and P. D'Amore. 1989. An activated form of transforming growth factor β is produced by cocultures of endothelial cells and pericytes. Proc. Natl. Acad. Sci. USA 86:4544.
27. Sato, Y., and D. Rifkin. 1989. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factorβ1-like molecule by plasmin during co-culture. J. Cell Biol. 109:309.
28. Shull, M. M., I. Ormsby, A. B. Kier, S. Pawlowski, R. J. Diebold, M. Yin, R. Alien, C. Sidman, G. Proetzel, D. Calvin, N. Annunziata, and T. Doetschman. 1992. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359:693.
29. Kulkarni, A. B., C.-G. Huh, D. Becker, A. Geiser, M. Lyght, K. C. Flanders, A. B. Roberts, M. B. Sporn, J. M. Ward, and S. Karlsson. 1993. Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA 90:770.
30. Geiser, A. G., J. J. Letterio, A. B. Kulkarni, S. Karlsson, A. B. Roberts, and M. B. Sporn. 1993. Transforming growth factor β1 (TGF-β1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-β1 null mouse phenotype. Proc. Natl. Acad. Sci. USA 90:9944.